Concur. I guess this is a prime announcement for the company to get on the front foot and give context to statistics.
My concern is that the closer the number gets to -1 the less impressive and less valuable the drug is...in my layman's view.
How do they communicate the overall reduction if it operates in phases. I imagine life expectancy is the ultimate method.
MT, be good to have an investor briefing on these results. What does it mean in reality. The 0.77 seems much less impressive than previous results, and is inline with some other trial drugs.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)